ArticleEmerging infectious diseases2021
Epidemiology and Spatial Emergence of Anaplasmosis, New York, USA, 2010‒2018.
Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 33 citations in OpenAlex.
- Early-life exposure to vector-borne pathogens in moose calves from Finland: molecular and phylogenetic evidence.BMC veterinary research · 2026Article
- Filling the Gap: Establishing a Statewide Tick and Tick-Borne Pathogen Surveillance Program.Insects · 2026Article
- Epidemiology and risk analysis of Powassan virus infection, New York state, USA, 2013-2023.Epidemiology and infection · 2026Article
- Retrospective Multicenter Study of Human Granulocytic Anaplasmosis, France, 2012-2024.Emerging infectious diseases · 2025Article
- Article
- Infections by Ehrlichia spp., Anaplasma spp. and Babesia spp. In Puerto Ordaz, Bolívar, VenezuelaBiomedica : revista del Instituto Nacional de Salud · 2025Article
- Comparative ecological analysis and predictive modeling of tick-borne pathogens.Journal of medical entomology · 2025Article
- New York State Climate Impacts Assessment Chapter 07: Human Health and Safety.Annals of the New York Academy of Sciences · 2024Review
- Assessing the impact of areal unit selection and the modifiable areal unit problem on associative statistics between cases of tick-borne disease and entomological indices.Journal of medical entomology · 2024Article
- Epidemiological, clinical, and laboratory characteristics of human granulocytic anaplasmosis in North India.Journal of clinical microbiology · 2024Article
- Assessing the Influence of Climate Change and Environmental Factors on the Top Tick-Borne Diseases in the United States: A Systematic Review.Microorganisms · 2023Review
- Identification and characterization of novel lineage 1 Powassan virus strains in New York State.Emerging microbes & infections · 2023Article
- From Tick to Test: A Comprehensive Review of Tick-Borne Disease Diagnostics and Surveillance Methods in the United States.Life (Basel, Switzerland) · 2023Review
- Tick Densities and Infection Prevalence on Coastal Islands in Massachusetts, USA: Establishing a Baseline.Insects · 2023Article
- Spatiotemporal distribution of Borrelia miyamotoi (Spirochaetales: Spirochaetaceae) and coinfection with other tick-borne pathogens in host-seeking Ixodes scapularis (Acari: Ixodidae) from New York State, USA.Journal of medical entomology · 2023Article
- Human-BitingMicroorganisms · 2023Article
- Anaplasmosis-Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature.Open forum infectious diseases · 2023Article
- The added value of One Health surveillance: data from questing ticks can provide an early signal for anaplasmosis outbreaks in animals and humans.Canadian journal of public health = Revue canadienne de sante publique · 2023Article
- Associations of Anaplasma phagocytophilum Bacteria Variants in Ixodes scapularis Ticks and Humans, New York, USA.Emerging infectious diseases · 2023Article
- Neurological Pain, Psychological Symptoms, and Diagnostic Struggles among Patients with Tick-Borne Diseases.Healthcare (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 7 institutions in 1 country.
Funding
Abstract
Human granulocytic anaplasmosis, a tickborne disease caused by the bacterium Anaplasma phagocytophilum, was first identified during 1994 and is now an emerging public health threat in the United States. New York state (NYS) has experienced a recent increase in the incidence of anaplasmosis. We analyzed human case surveillance and tick surveillance data collected by the NYS Department of Health for spatiotemporal patterns of disease emergence. We describe the epidemiology and growing incidence of anaplasmosis cases reported during 2010-2018. Spatial analysis showed an expanding hot spot of anaplasmosis in the Capital Region, where incidence increased >8-fold. The prevalence of A. phagocytophilum increased greatly within tick populations in the Capital Region over the same period, and entomologic risk factors were correlated with disease incidence at a local level. These results indicate that anaplasmosis is rapidly emerging in a geographically focused area of NYS, likely driven by localized changes in exposure risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.